DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,891 | +3.4% | 1,039 | 0.0% | 0.23% | +6.5% |
| Q2 2023 | $249,461 | -25.7% | 1,039 | -21.9% | 0.22% | +1.9% |
| Q1 2023 | $335,560 | -10.0% | 1,331 | -5.3% | 0.21% | -13.2% |
| Q4 2022 | $373,000 | +0.5% | 1,406 | -2.1% | 0.24% | -9.7% |
| Q3 2022 | $371,000 | +0.8% | 1,436 | -1.1% | 0.27% | +8.5% |
| Q2 2022 | $368,000 | -18.8% | 1,452 | -6.0% | 0.25% | -3.9% |
| Q1 2022 | $453,000 | -10.8% | 1,544 | 0.0% | 0.26% | -6.5% |
| Q4 2021 | $508,000 | +7.4% | 1,544 | -0.5% | 0.28% | -2.1% |
| Q3 2021 | $473,000 | +12.9% | 1,552 | -0.6% | 0.28% | +11.0% |
| Q2 2021 | $419,000 | +20.7% | 1,562 | +1.2% | 0.25% | +10.9% |
| Q1 2021 | $347,000 | +3.3% | 1,543 | +2.0% | 0.23% | -5.0% |
| Q4 2020 | $336,000 | -0.3% | 1,513 | -3.2% | 0.24% | -10.4% |
| Q3 2020 | $337,000 | +22.1% | 1,563 | 0.0% | 0.27% | +10.7% |
| Q2 2020 | $276,000 | +34.0% | 1,563 | +5.0% | 0.24% | +16.8% |
| Q1 2020 | $206,000 | -13.4% | 1,489 | -9.5% | 0.21% | -7.1% |
| Q3 2019 | $238,000 | +1.3% | 1,645 | 0.0% | 0.22% | -11.1% |
| Q2 2019 | $235,000 | +9.8% | 1,645 | +1.7% | 0.25% | +7.7% |
| Q1 2019 | $214,000 | – | 1,618 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |